258 related articles for article (PubMed ID: 33579366)
1. Pluripotent stem cell-induced skeletal muscle progenitor cells with givinostat promote myoangiogenesis and restore dystrophin in injured Duchenne dystrophic muscle.
Xuan W; Khan M; Ashraf M
Stem Cell Res Ther; 2021 Feb; 12(1):131. PubMed ID: 33579366
[TBL] [Abstract][Full Text] [Related]
2. Transplantation of Dystrophin Expressing Chimeric Human Cells of Myoblast/Mesenchymal Stem Cell Origin Improves Function in Duchenne Muscular Dystrophy Model.
Siemionow M; Szilagyi E; Cwykiel J; Domaszewska-Szostek A; Heydemann A; Garcia-Martinez J; Siemionow K
Stem Cells Dev; 2021 Feb; 30(4):190-202. PubMed ID: 33349121
[TBL] [Abstract][Full Text] [Related]
3. Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy.
He R; Li H; Wang L; Li Y; Zhang Y; Chen M; Zhu Y; Zhang C
Biol Res; 2020 May; 53(1):22. PubMed ID: 32430065
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
[TBL] [Abstract][Full Text] [Related]
5. Chemokine/ITGA4 Interaction Directs iPSC-Derived Myogenic Progenitor Migration to Injury Sites in Aging Muscle for Regeneration.
Ashraf M; Tipparaju SM; Kim JW; Xuan W
Cells; 2023 Jul; 12(14):. PubMed ID: 37508502
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells derived from human induced pluripotent stem cells improve the engraftment of myogenic cells by secreting urokinase-type plasminogen activator receptor (uPAR).
Elhussieny A; Nogami K; Sakai-Takemura F; Maruyama Y; Takemura N; Soliman WT; Takeda S; Miyagoe-Suzuki Y
Stem Cell Res Ther; 2021 Oct; 12(1):532. PubMed ID: 34627382
[TBL] [Abstract][Full Text] [Related]
7. Induction of CCAAT/Enhancer-Binding Protein β Expression With the Phosphodiesterase Inhibitor Isobutylmethylxanthine Improves Myoblast Engraftment Into Dystrophic Muscle.
Lala-Tabbert N; Fu D; Wiper-Bergeron N
Stem Cells Transl Med; 2016 Apr; 5(4):500-10. PubMed ID: 26941360
[TBL] [Abstract][Full Text] [Related]
8. Preclinical studies in the mdx mouse model of duchenne muscular dystrophy with the histone deacetylase inhibitor givinostat.
Consalvi S; Mozzetta C; Bettica P; Germani M; Fiorentini F; Del Bene F; Rocchetti M; Leoni F; Monzani V; Mascagni P; Puri PL; Saccone V
Mol Med; 2013 May; 19(1):79-87. PubMed ID: 23552722
[TBL] [Abstract][Full Text] [Related]
9. Exosome-Derived Dystrophin from Allograft Myogenic Progenitors Improves Cardiac Function in Duchenne Muscular Dystrophic Mice.
Su X; Jin Y; Shen Y; Ju C; Cai J; Liu Y; Kim IM; Wang Y; Yu H; Weintraub NL; Jiang M; Tang Y
J Cardiovasc Transl Res; 2018 Oct; 11(5):412-419. PubMed ID: 30155598
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9-Based Dystrophin Restoration Reveals a Novel Role for Dystrophin in Bioenergetics and Stress Resistance of Muscle Progenitors.
Matre PR; Mu X; Wu J; Danila D; Hall MA; Kolonin MG; Darabi R; Huard J
Stem Cells; 2019 Dec; 37(12):1615-1628. PubMed ID: 31574188
[TBL] [Abstract][Full Text] [Related]
11. Effect of heme oxygenase-1 on the differentiation of human myoblasts and the regeneration of murine skeletal muscles after acute and chronic injury.
Głowniak-Kwitek U; Caballero AL; Bronisz-Budzyńska I; Kozakowska M; Andrysiak K; Stępniewski J; Łoboda A; Dulak J
Pharmacol Rep; 2023 Apr; 75(2):397-410. PubMed ID: 36918494
[TBL] [Abstract][Full Text] [Related]
12. The pan HDAC inhibitor Givinostat improves muscle function and histological parameters in two Duchenne muscular dystrophy murine models expressing different haplotypes of the LTBP4 gene.
Licandro SA; Crippa L; Pomarico R; Perego R; Fossati G; Leoni F; Steinkühler C
Skelet Muscle; 2021 Jul; 11(1):19. PubMed ID: 34294164
[TBL] [Abstract][Full Text] [Related]
13. Givinostat as metabolic enhancer reverting mitochondrial biogenesis deficit in Duchenne Muscular Dystrophy.
Giovarelli M; Zecchini S; Catarinella G; Moscheni C; Sartori P; Barbieri C; Roux-Biejat P; Napoli A; Vantaggiato C; Cervia D; Perrotta C; Clementi E; Latella L; De Palma C
Pharmacol Res; 2021 Aug; 170():105751. PubMed ID: 34197911
[TBL] [Abstract][Full Text] [Related]
14. Cardiac Protection after Systemic Transplant of Dystrophin Expressing Chimeric (DEC) Cells to the mdx Mouse Model of Duchenne Muscular Dystrophy.
Siemionow M; Malik M; Langa P; Cwykiel J; Brodowska S; Heydemann A
Stem Cell Rev Rep; 2019 Dec; 15(6):827-841. PubMed ID: 31612351
[TBL] [Abstract][Full Text] [Related]
15. Autologous Cell Therapy Approach for Duchenne Muscular Dystrophy using PiggyBac Transposons and Mesoangioblasts.
Iyer PS; Mavoungou LO; Ronzoni F; Zemla J; Schmid-Siegert E; Antonini S; Neff LA; Dorchies OM; Jaconi M; Lekka M; Messina G; Mermod N
Mol Ther; 2018 Apr; 26(4):1093-1108. PubMed ID: 29503200
[TBL] [Abstract][Full Text] [Related]
16. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
17. miR-146a deficiency does not aggravate muscular dystrophy in mdx mice.
Bronisz-Budzyńska I; Chwalenia K; Mucha O; Podkalicka P; Karolina-Bukowska-Strakova ; Józkowicz A; Łoboda A; Kozakowska M; Dulak J
Skelet Muscle; 2019 Aug; 9(1):22. PubMed ID: 31412923
[TBL] [Abstract][Full Text] [Related]
18. Amniotic Membrane-Derived Stromal Cells Release Extracellular Vesicles That Favor Regeneration of Dystrophic Skeletal Muscles.
Sandonà M; Esposito F; Cargnoni A; Silini A; Romele P; Parolini O; Saccone V
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569832
[TBL] [Abstract][Full Text] [Related]
19. Restoration of Functional Full-Length Dystrophin After Intramuscular Transplantation of Foamy Virus-Transduced Myoblasts.
Meng J; Sweeney NP; Doreste B; Muntoni F; McClure M; Morgan J
Hum Gene Ther; 2020 Feb; 31(3-4):241-252. PubMed ID: 31801386
[TBL] [Abstract][Full Text] [Related]
20. Loss of full-length dystrophin expression results in major cell-autonomous abnormalities in proliferating myoblasts.
Gosselin MRF; Mournetas V; Borczyk M; Verma S; Occhipinti A; Róg J; Bozycki L; Korostynski M; Robson SC; Angione C; Pinset C; Gorecki DC
Elife; 2022 Sep; 11():. PubMed ID: 36164827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]